NPI: 1295013316 · PRENTISS, MS 39474 · Critical Access Hospital · NPI assigned 07/22/2011
Authorized official HESTER, BEN controls 20+ related entities in our dataset. Read more
| Authorized Official | HESTER, BEN (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 07/22/2011 |
Other providers sharing the same authorized official: HESTER, BEN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,016 | $641K |
| 2019 | 16,856 | $760K |
| 2020 | 9,976 | $400K |
| 2021 | 12,247 | $468K |
| 2022 | 14,742 | $536K |
| 2023 | 14,646 | $584K |
| 2024 | 10,259 | $411K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 9,979 | 8,555 | $1.25M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,975 | 2,670 | $493K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,012 | 2,597 | $313K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,126 | 1,001 | $236K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5,359 | 1,116 | $206K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,960 | 1,769 | $170K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,079 | 1,764 | $120K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,582 | 3,138 | $109K |
| 71046 | Radiologic examination, chest; 2 views | 2,136 | 1,897 | $95K |
| 70450 | Computed tomography, head or brain; without contrast material | 969 | 869 | $90K |
| 87634 | 2,067 | 1,753 | $87K | |
| 71045 | Radiologic examination, chest; single view | 1,761 | 1,547 | $66K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,107 | 1,789 | $65K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,500 | 2,179 | $54K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,264 | 1,111 | $50K |
| 80053 | Comprehensive metabolic panel | 5,923 | 5,025 | $48K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6,687 | 5,393 | $36K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,281 | 1,073 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,409 | 1,060 | $28K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,114 | 965 | $26K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 773 | 685 | $23K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 191 | 113 | $21K |
| 36415 | Collection of venous blood by venipuncture | 6,640 | 5,379 | $17K |
| 84484 | 2,042 | 1,653 | $16K | |
| A9270 | Non-covered item or service | 3,034 | 2,384 | $14K |
| 82553 | 1,990 | 1,609 | $14K | |
| 81001 | 4,754 | 4,140 | $11K | |
| 87430 | 884 | 783 | $11K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 368 | 321 | $9K |
| 83880 | 378 | 324 | $9K | |
| 82550 | 2,306 | 1,670 | $9K | |
| 36592 | 1,033 | 899 | $6K | |
| 81025 | 1,083 | 943 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 820 | 670 | $6K |
| G0378 | Hospital observation service, per hour | 13 | 13 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 755 | 669 | $5K |
| 87081 | 819 | 726 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 41 | 37 | $5K |
| 80061 | Lipid panel | 420 | 387 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 60 | 53 | $3K |
| 82150 | 586 | 519 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 15 | 13 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 21 | 14 | $2K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 52 | 12 | $2K |
| 73562 | 39 | 39 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 286 | 266 | $2K |
| 87186 | 160 | 147 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,900 | 1,675 | $1K |
| 87077 | 162 | 148 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | 132 | 116 | $1K |
| 72100 | 13 | 13 | $870.62 | |
| 73610 | 13 | 12 | $845.68 | |
| 87420 | 58 | 55 | $707.82 | |
| 97162 | 15 | 12 | $505.75 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13 | 12 | $463.15 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 460 | 397 | $443.50 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14 | 14 | $430.67 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,487 | 1,271 | $323.27 |
| 85378 | 32 | 30 | $284.51 | |
| 82962 | 107 | 85 | $243.10 | |
| 83735 | 15 | 12 | $85.29 | |
| 85610 | 26 | 25 | $77.94 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 365 | 325 | $34.48 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 77 | 60 | $0.00 |